Lista de

Neoplasms
46
"Galectin-1: A jack-of-all-trades in the resolution of acute and chronic inflammation" (2017) Sundblad, V.; Morosi, L.G.; Geffner, J.R.; Rabinovich, G.A. Journal of Immunology. 199(11):3721-3730
"Galectins: emerging regulatory checkpoints linking tumor immunity and angiogenesis" (2017) Méndez-Huergo, S.P.; Blidner, A.G.; Rabinovich, G.A. Current Opinion in Immunology. 45:8-15
"Degenerate cysteine patterns mediate two redox sensing mechanisms in the papillomavirus E7 oncoprotein" (2017) Camporeale, G.;Lorenzo, J.R.;Thomas, M.G. (...)Alonso, L.G. Redox Biology. 11:38-50
"Biological relevance of Hsp90-binding immunophilins in cancer development and treatment" (2016) Mazaira, G.I.;Camisay, M.F.;De Leo, S. (...)Galigniana, M.D. International Journal of Cancer. 138(4):797-808
"Mathematical modelling of microtumour infiltration based on in vitro experiments" (2016) Luján, E.;Guerra, L.N.;Soba, A. (...)Suárez, C. Integrative Biology (United Kingdom). 8(8):879-885
"Driving CARs into Sweet Roads: Targeting Glycosylated Antigens in Cancer" (2016) Blidner, A.G.; Mariño, K.V.; Rabinovich, G.A. Immunity. 44(6):1248-1250
"Uncovering disease mechanisms through network biology in the era of Next Generation Sequencing" (2016) Piñero, J.;Berenstein, A.;Gonzalez-Perez, A. (...)Furlong, L.I. Scientific Reports. 6
"Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways" (2016) Rabinovich, G.A.; Conejo-García, J.R. Journal of Molecular Biology. 428(16):3266-3281
"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54
"Glyco-nano-oncology: Novel therapeutic opportunities by combining small and sweet" (2016) Hockl, P.F.;Wolosiuk, A.;Pérez-Sáez, J.M. (...)Rabinovich, G.A. Pharmacological Research. 109:45-54
"Role of RSUME in inflammation and cancer" (2015) Antico Arciuch, V.G.; Tedesco, L.; Fuertes, M.; Arzt, E. FEBS Letters. 589(22):3330-3335
"Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer" (2015) Sersa, G.;Teissie, J.;Cemazar, M. (...)Miklavcic, D. Cancer Immunology, Immunotherapy. 64(10):1315-1327
"Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer" (2015) Sersa, G.;Teissie, J.;Cemazar, M. (...)Miklavcic, D. Cancer Immunology, Immunotherapy. 64(10):1315-1327
"OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis" (2014) Astorgues-Xerri, L. European journal of cancer (Oxford, England : 1990). 50(14):2463-2477
"OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis" (2014) Astorgues-Xerri, L. European journal of cancer (Oxford, England : 1990). 50(14):2463-2477
"Galectin-8: A matricellular lectin with key roles in angiogenesis" (2014) Troncoso, M.F.;Ferragut, F.;Bacigalupo, M.L. (...)Elola, M.T. Glycobiology. 24(10):907-914
"Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors" (2014) Elola, M.T.;Ferragut, F.;Cárdenas Delgado, V.M. (...)Rabinovich, G.A. Histology and Histopathology. 29(9):1093-1105
"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors" (2014) Croci, D.O.;Cerliani, J.P.;Dalotto-Moreno, T. (...)Rabinovich, G.A. Cell. 156(4):744-758
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment" (2014) Croci, D.O.;Cerliani, J.P.;Pinto, N.A. (...)Rabinovich, G.A. Glycobiology. 24(12):1283-1290
"Hsp90-binding immunophilins as a potential new platform for drug treatment" (2013) Erlejman, A.G.; Lagadari, M.; Galigniana, M.D. Future Medicinal Chemistry. 5(5):591-607
"Vascular galectins: Regulators of tumor progression and targets for cancer therapy" (2013) Thijssen, V.L.; Rabinovich, G.A.; Griffioen, A.W. Cytokine and Growth Factor Reviews. 24(6):547-558
"A natural antiviral and immunomodulatory compound with antiangiogenic properties" (2012) Bueno, C.A.; Lombardi, M.G.; Sales, M.E.; Alché, L.E. Microvascular Research. 84(3):235-241
"Regulatory Circuits Mediated by Lectin-Glycan Interactions in Autoimmunity and Cancer" (2012) Rabinovich, G.; Croci, D.O. Immunity. 36(3):322-335
"Interaction of p53 with tumor suppressive and oncogenic signaling pathways to control cellular reactive oxygen species production" (2011) Ladelfa, M.F.; Toledo, M.F.; Laiseca, J.E.; Monte, M. Antioxidants and Redox Signaling. 15(6):1749-1761
"FKBP51 and FKBP52 in signaling and disease" (2011) Storer, C.L.;Dickey, C.A.;Galigniana, M.D. (...)Cox, M.B. Trends in Endocrinology and Metabolism. 22(12):481-490
"Modulation of endothelial cell migration and angiogenesis: A novel function for the "tandem-repeat" lectin galectin-8" (2011) Cárdenas Delgado, V.M.;Nugnes, L.G.;Colombo, L.L. (...)Elola, M.T. FASEB Journal. 25(1):242-254
"Overcoming the hurdles of tumor immunity by targeting regulatory pathways in innate and adaptive immune cells" (2010) Zwirner, N.W.; Croci, D.O.; Domaica, C.I.; Rabinovich, G.A. Current Pharmaceutical Design. 16(3):255-267
"Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites" (2010) Belloso, W.H.;Orellana, L.C.;Grinsztejn, B. (...)Losso, M.H. HIV Medicine. 11(9):554-564
"Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites" (2010) Belloso, W.H.;Orellana, L.C.;Grinsztejn, B. (...)Losso, M.H. HIV Medicine. 11(9):554-564
"Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings" (2010) Laderach, D.J.;Compagno, D.;Toscano, M.A. (...)Rabinovich, G.A. IUBMB Life. 62(1):1-13
"When the optimal is not the best: Parameter estimation in complex biological models" (2010) Fernández Slezak, D.;Suárez, C.;Cecchi, G.A. (...)Stolovitzky, G. PLoS ONE. 5(10)
"Emerging roles of ATF2 and the dynamic AP1 network in cancer" (2010) Lopez-Bergami, P.; Lau, E.; Ronai, Z. Nature Reviews Cancer. 10(1):65-76
"Cellular inactivation and antitumor efficacy of a new zinc phthalocyanine with potential use in photodynamic therapy" (2008) Vittar, N.B.R.;Prucca, C.G.;Strassert, C. (...)Rivarola, V.A. International Journal of Biochemistry and Cell Biology. 40(10):2192-2205
"Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer" (2008) Salatino, M.;Croci, D.O.;Bianco, G.A. (...)Rabinovich, G.A. Expert Opinion on Biological Therapy. 8(1):45-57
"Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment" (2007) Croci, D.O.;Zacarías Fluck, M.F.;Rico, M.J. (...)Scharovsky, O.G. Cancer Immunology, Immunotherapy. 56(11):1687-1700
"The pathology of pre-mRNA splicing: A meeting in the Italian Alps. Workshop on Pre-mRNA Processing and Disease" (2007) Caceres, J.F.; Krainer, A.R.; Kornblihtt, A.R. EMBO Reports. 8(8):730-734
"Ion transport in tumors under electrochemical treatment: In vivo, in vitro and in silico modeling" (2007) Colombo, L.;González, G.;Marshall, G. (...)Turjanski, P. Bioelectrochemistry. 71(2):223-232
"Inhibition of heme oxygenase-1 interferes with the transforming activity of the Kaposi sarcoma herpesvirus-encoded G protein-coupled receptor" (2006) Marinissen, M.J.;Tanos, T.;Bolós, M. (...)Cuadrado, A. Journal of Biological Chemistry. 281(16):11332-11346
"Development of β-Lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels" (2005) Reinicke, K.E.;Bey, E.A.;Bentle, M.S. (...)Boothman, D.A. Clinical Cancer Research. 11(8):3055-3064
"Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients" (2002) De Cavanagh, E.M.V.;Honegger, A.E.;Hofer, E. (...)Fraga, C. Cancer. 94(12):3247-3251
"Porphyrins, porphyrias, cancer and photodynamic therapy - a model for carcinogenesis" (1993) Del Batlle, C.A.M. Journal of Photochemistry and Photobiology, B: Biology. 20(1):5-22
"Natural inhibitors of blood coagulation and fibrinolysis in patients with lupus anticoagulant" (1992) Kordich, L.C.;Forastiero, R.R.;Basilotta, E. (...)Carreras, L.O. Blood Coagulation and Fibrinolysis. 3(6):765-771
"Cancer and BCG " (1981) Rumi, L.S. Acta Physiologica Latino-Americana. 31(1):25-34